CYP2D6 -1584C>G promoter polymorphism and debrisoquine ultrarapid hydroxylation in healthy volunteers.

doi:10.2217/pgs.13.181

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Community

Back to search

Article

CYP2D6 -1584C>G promoter polymorphism and debrisoquine ultrarapid hydroxylation in healthy volunteers.

Pharmacogenomics - 1 Dec 2013

Llerena Adrian, Dorado Pedro, Ramírez Ronald, Calzadilla Luis R, Peñas-Lledó Eva, Álvarez Mayra, Naranjo María E G, González Idilio, Pérez Bárbaro

Abstract excerpt

BACKGROUND & AIM: The CYP2D6 -1584C>G polymorphism (rs1080985) has been identified as a major factor for CYP2D6 expression and function, with the mutant -1584G promoter type being consistently associated with significantly greater expression than -1584C. It may therefore be associated with ultrarapid metabolism. The objective of the present study was to explore the relationship between the CYP2D6 -1584C>G...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cytochrome P-450 CYP2D6

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Debrisoquin

Share to Gene Expression Regulation

Share to Healthy Volunteers

Share to Heterozygote

Share to Hydroxylation

Share to Polymorphism, Genetic

Share to Promoter Regions, Genetic

Source

Open in PubMed

Identifiers

PMID: 24279852
DOI: 10.2217/pgs.13.181

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

CYP2D6 -1584C>G promoter polymorphism and debrisoquine ultrarapid hydroxylation in healthy volunteers.PMID 24279852Read ↗

Ultrarapid hydroxylation of debrisoquine in a Swedish population. Analysis of the molecular genetic basis.Semantic proximity Read ↗

Inherited amplification of an active gene in the cytochrome P450 CYP2D locus as a cause of ultrarapid metabolism of debrisoquine.Semantic proximity Read ↗

Pharmacogenetics of Debrisoquine and its Use as a Marker For CYP2D6 Hydroxylation CapacitySemantic proximity Read ↗

Cytochrome P450 2D6: overview and update on pharmacology, genetics, biochemistry.Semantic proximity Read ↗

Pharmacogenetics of cytochrome P4502D6: genetic background and clinical implicationSemantic proximity Read ↗

PCR-based genotyping for duplicated and deleted CYP2D6 genes.Semantic proximity Read ↗

Inhibition of debrisoquine hydroxylation with quinidine in subjects with three or more functional CYP2D6 genes.Semantic proximity Read ↗

Cytochrome P450 2D6 variants in a Caucasian population: allele frequencies and phenotypic consequences.Semantic proximity Read ↗

Analysis of the CYP2D6 gene mutations and their consequences for enzyme function in a West African population.Semantic proximity Read ↗

Characterization of the CYP2D6*29 allele commonly present in a black Tanzanian population causing reduced catalytic activity.Semantic proximity Read ↗

Ten percent of North Spanish individuals carry duplicated or triplicated CYP2D6 genes associated with ultrarapid metabolism of debrisoquine.Semantic proximity Read ↗

Interpretation of a simple PCR analysis of the CYP2D6(A) and CYP2D6(B) null alleles associated with the debrisoquine/sparteine genetic polymorphism.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.